Genomenon Acquires The Jackson Laboratory's Clinical Knowledgebase (CKB) to Fuel its Mission to Curate the Human Genome
ANN ARBOR, Mich., May 8, 2024 /PRNewswire-PRWeb/ -- Genomenon, a genomic intelligence company today announced its acquisition of the Clinical Knowledgebase (CKB) from The Jackson Laboratory (JAX). CKB is the leading curated variant database used for interpreting complex cancer genomic profiles by some of the world's premier oncology labs. This strategic acquisition enables Genomenon to provide an unprecedented understanding of the genome, with insights now covering both germline and somatic variants, furthering its lead in the race to curate the genome. Financial terms of the acquisition were not disclosed.
- This strategic acquisition enables Genomenon to provide an unprecedented understanding of the genome, with insights now covering both germline and somatic variants, furthering its lead in the race to curate the genome.
- "The acquisition of CKB is a significant step in Genomenon's mission to curate the entire human genome," shared Mike Klein, CEO of Genomenon.
- "The acquisition of CKB is a significant step in Genomenon's mission to curate the entire human genome," shared Mike Klein, CEO of Genomenon.
- In June 2023, Genomenon announced the acquisition of Boston Genetics as part of its mission to curate the human genome.